NAI Hiffman Services NAI Hiffman Inspired Quote NAI Hiffman Website Homepage NAI Hiffman Blog Post
Cantigny CTA Module Section Cantigny Shop Module Cantigny Homepage Design Cantigny Social Media Widget
orgSource Mobile Homepage orgSource Newsletter Subscribe Widget orgSource Homepage Design orgSource Blog Post Module

Digital Diagnostics

In April 2018,  Digital Diagnostics (formerly known as IDx) became the first company to ever receive FDA clearance for an AI diagnostic platform that makes a diagnosis without physician input. This achievement did not happen overnight – it was the culmination of decades of research by founder Dr. Michael Abramoff on automated image analysis, combined with decades of research on how clinicians diagnose disease. Digital Diagnostics’s first FDA-cleared product is the AI diagnostic platform Dr. Abramoff had envisioned years earlier. The platform, called IDx-DR, detects diabetic retinopathy and macular edema in primary care. After completing a rigorous prospective, a pre-registered clinical trial at primary care sites across the country, IDx-DR became the first FDA-cleared AI diagnostic system to make a diagnosis without physician input.

In Spring 2020, Digital Diagnostics approached Frey with a rebranding and website design project to align with their growth. After a complete brand discovery process, Frey created a new brand and materials that aligned with their forward-thinking and innovative mission. Since the launch of the rebrand, Digital Diagnostics has come back to Frey for additional website enhancements and marketing support.

what we did
  • Research
  • Brand Strategy
  • Conceptual Development
  • Visual Identity
  • Branding Systems
  • Printed Collateral
  • UI/UX Design
  • Web Development
  • Application Design & Development
  • Digital Marketing
  • Social Media Marketing
  • SEO
  • Motion Graphics
DIG Mockup Phone 3 Screens

Next Project

BMO Tower / 770 North